Free Trial

CorMedix (CRMD) News Today

CorMedix logo
$8.84 -0.55 (-5.81%)
As of 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
CorMedix Inc. stock logo
Renaissance Technologies LLC Makes New $1.09 Million Investment in CorMedix Inc. (NASDAQ:CRMD)
Renaissance Technologies LLC purchased a new stake in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 134,000 shares of the company'
CorMedix Inc. stock logo
CorMedix (CRMD) Expected to Announce Earnings on Tuesday
CorMedix (NASDAQ:CRMD) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-cormedix-inc-stock-1/)
CorMedix Inc. stock logo
CorMedix Inc. (NASDAQ:CRMD) Receives Average Rating of "Buy" from Brokerages
Shares of CorMedix Inc. (NASDAQ:CRMD - Get Free Report) have received an average rating of "Buy" from the seven research firms that are currently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has issued a strong bu
CorMedix Inc. stock logo
CorMedix Inc. (NASDAQ:CRMD) Holdings Raised by JPMorgan Chase & Co.
JPMorgan Chase & Co. increased its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 40.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 273,218 shares of the company's stock after purchasing an add
CorMedix Inc. stock logo
Geode Capital Management LLC Acquires 108,356 Shares of CorMedix Inc. (NASDAQ:CRMD)
Geode Capital Management LLC increased its holdings in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 8.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,392,820 shares of the company's stock after buyin
CorMedix Inc. stock logo
CorMedix (NASDAQ:CRMD) Stock Price Up 4.7% - Should You Buy?
CorMedix (NASDAQ:CRMD) Stock Price Up 4.7% - Here's What Happened
CorMedix Inc. stock logo
Advisory Services Network LLC Purchases New Shares in CorMedix Inc. (NASDAQ:CRMD)
Advisory Services Network LLC acquired a new position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 51,600 shares of the company's stock, valued at
CorMedix Inc. stock logo
CorMedix Inc. (NASDAQ:CRMD) Shares Bought by Vanguard Group Inc.
Vanguard Group Inc. lifted its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 10.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,378,191 shares of the company's stock after acquiring an additional 309,514 shares during the period. Va
CorMedix Inc. stock logo
CorMedix's (CRMD) "Buy" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and set a $12.00 price objective on shares of CorMedix in a research note on Wednesday.
CorMedix Inc. stock logo
CorMedix (NASDAQ:CRMD) Given Buy Rating at D. Boral Capital
D. Boral Capital reissued a "buy" rating and issued a $15.00 target price on shares of CorMedix in a research report on Tuesday.
CorMedix reports preliminary Q1 revenue $39M, consensus $32.2M.
CorMedix Inc. stock logo
Raymond James Financial Inc. Purchases New Holdings in CorMedix Inc. (NASDAQ:CRMD)
Raymond James Financial Inc. acquired a new position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 115,661 shares of the company's stock, valued at approximately $937,
RBC Capital Remains a Buy on Cormedix (CRMD)
CorMedix Inc. stock logo
CorMedix (NASDAQ:CRMD) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of CorMedix from a "sell" rating to a "hold" rating in a research report on Tuesday.
CorMedix Inc. stock logo
CorMedix Inc. (NASDAQ:CRMD) Receives Average Recommendation of "Buy" from Brokerages
CorMedix Inc. (NASDAQ:CRMD - Get Free Report) has received an average rating of "Buy" from the eight ratings firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The
CorMedix Inc. stock logo
Q1 Earnings Estimate for CorMedix Issued By Leerink Partnrs
CorMedix Inc. (NASDAQ:CRMD - Free Report) - Investment analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for CorMedix in a report released on Tuesday, March 25th. Leerink Partnrs analyst R. Ruiz anticipates that the company will earn $0.23 per share for the quart
CorMedix Inc. stock logo
CorMedix (NASDAQ:CRMD) Given "Outperform" Rating at Royal Bank of Canada
Royal Bank of Canada restated an "outperform" rating and issued a $12.00 price objective on shares of CorMedix in a research report on Wednesday.
CorMedix Inc. stock logo
CorMedix (NASDAQ:CRMD) Given New $12.00 Price Target at Needham & Company LLC
Needham & Company LLC cut their price target on CorMedix from $18.00 to $12.00 and set a "buy" rating on the stock in a research note on Wednesday.
CorMedix Inc. stock logo
CorMedix (NASDAQ:CRMD) Shares Gap Down - Here's What Happened
CorMedix (NASDAQ:CRMD) Shares Gap Down - Here's Why
CorMedix Inc. stock logo
Traders Buy Large Volume of Call Options on CorMedix (NASDAQ:CRMD)
CorMedix Inc. (NASDAQ:CRMD - Get Free Report) saw unusually large options trading activity on Tuesday. Stock investors bought 4,076 call options on the company. This is an increase of approximately 170% compared to the average daily volume of 1,508 call options.
CorMedix Inc. stock logo
CorMedix's (CRMD) Buy Rating Reaffirmed at D. Boral Capital
D. Boral Capital restated a "buy" rating and set a $15.00 price target on shares of CorMedix in a report on Tuesday.
CorMedix Inc. stock logo
CorMedix (NASDAQ:CRMD) Issues Earnings Results, Beats Estimates By $0.17 EPS
CorMedix (NASDAQ:CRMD - Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.17. The firm had revenue of $30.00 million for the quarter, compared to the consensus estimate of $27.46 million. CorMedix's quarterly revenue was up 29900.0% compared to the same quarter last year.
CorMedix Inc. stock logo
CorMedix (NASDAQ:CRMD) Posts Earnings Results, Beats Expectations By $0.17 EPS
CorMedix (NASDAQ:CRMD - Get Free Report) released its earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.17. The business had revenue of $30.00 million during the quarter, compared to the consensus estimate of $27.46 million. The firm's quarterly revenue was up 29900.0% compared to the same quarter last year.
CorMedix Dives on Results
CorMedix shares tumble after order delay
Truist Financial Remains a Buy on Cormedix (CRMD)
Get CorMedix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter.

CRMD Media Mentions By Week

CRMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRMD
News Sentiment

0.60

0.72

Average
Medical
News Sentiment

CRMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRMD Articles
This Week

4

3

CRMD Articles
Average Week

Get CorMedix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CRMD) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners